Which has better earnings and valuation, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.78 HealthEquity $1.31B 5.61 $215.20M $2.77 32.18

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.36% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 15.33% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% HealthEquity 17.36% 15.33% 9.51%

Does the media refer more to MCK or HQY?

In the previous week, McKesson had 13 more articles in the media than HealthEquity. MarketBeat recorded 17 mentions for McKesson and 4 mentions for HealthEquity. McKesson's average media sentiment score of 0.57 beat HealthEquity's score of 0.13 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 6 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive HealthEquity 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.78 Henry Schein $13.18B 0.71 $398M $3.43 24.50

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Henry Schein 2.96% 15.97% 5.56%

Does the media favor MCK or HSIC?

In the previous week, McKesson had 11 more articles in the media than Henry Schein. MarketBeat recorded 17 mentions for McKesson and 6 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.89 beat McKesson's score of 0.57 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 6 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Henry Schein 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MCK or MMSI?

In the previous week, McKesson had 12 more articles in the media than Merit Medical Systems. MarketBeat recorded 17 mentions for McKesson and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.96 beat McKesson's score of 0.57 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 6 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Merit Medical Systems 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, MCK or NEOG?

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.78 Neogen $870.40M 3.11 -$7.90M -$0.03 N/A

Is MCK or NEOG more profitable?

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Neogen -0.91% 2.78% 1.74%

Does the media favor MCK or NEOG?

In the previous week, McKesson had 3 more articles in the media than Neogen. MarketBeat recorded 17 mentions for McKesson and 14 mentions for Neogen. McKesson's average media sentiment score of 0.57 beat Neogen's score of 0.08 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 6 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Neogen 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer MCK or AMN?

In the previous week, McKesson had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 17 mentions for McKesson and 3 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat McKesson's score of 0.57 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 6 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

McKesson (MCK) Competitors

$903.14 +4.32 (+0.48%)

Closing price 03:59 PM Eastern

Extended Trading

$891.42 -11.72 (-1.30%)

As of 05:22 PM Eastern

Compare

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

Should you buy McKesson stock or one of its competitors? McKesson's main competitors and comparable companies include HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), Neogen (NEOG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

McKesson has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.24, indicating that its stock price is 76% less volatile than the broader market.

In the previous week, McKesson had 13 more articles in the media than HealthEquity. MarketBeat recorded 17 mentions for McKesson and 4 mentions for HealthEquity. McKesson's average media sentiment score of 0.57 beat HealthEquity's score of 0.13 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	6 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
HealthEquity	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.78
HealthEquity	$1.31B	5.61	$215.20M	$2.77	32.18

HealthEquity has a net margin of 17.36% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 15.33% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
HealthEquity	17.36%	15.33%	9.51%

McKesson currently has a consensus price target of $973.44, suggesting a potential upside of 9.53%. HealthEquity has a consensus price target of $112.20, suggesting a potential upside of 25.87%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

Summary

HealthEquity beats McKesson on 10 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.78
Henry Schein	$13.18B	0.71	$398M	$3.43	24.50

In the previous week, McKesson had 11 more articles in the media than Henry Schein. MarketBeat recorded 17 mentions for McKesson and 6 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.89 beat McKesson's score of 0.57 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	6 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Henry Schein	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Henry Schein	2.96%	15.97%	5.56%

McKesson currently has a consensus price target of $973.44, indicating a potential upside of 9.53%. Henry Schein has a consensus price target of $92.93, indicating a potential upside of 10.58%. Given Henry Schein's higher possible upside, analysts plainly believe Henry Schein is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

Summary

Henry Schein beats McKesson on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

McKesson (NYSE:MCK) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

McKesson has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market.

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.78
Merit Medical Systems	$1.52B	3.40	$128.49M	$2.42	35.71

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 9.53%. Merit Medical Systems has a consensus price target of $100.00, indicating a potential upside of 15.73%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Merit Medical Systems has a net margin of 9.22% compared to McKesson's net margin of 1.12%. Merit Medical Systems' return on equity of 13.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Merit Medical Systems	9.22%	13.75%	8.10%

In the previous week, McKesson had 12 more articles in the media than Merit Medical Systems. MarketBeat recorded 17 mentions for McKesson and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.96 beat McKesson's score of 0.57 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	6 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Merit Medical Systems	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats McKesson on 12 of the 17 factors compared between the two stocks.

How does McKesson compare to Neogen?

McKesson (NYSE:MCK) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

McKesson currently has a consensus target price of $973.44, indicating a potential upside of 9.53%. Neogen has a consensus target price of $12.67, indicating a potential upside of 2.13%. Given McKesson's stronger consensus rating and higher possible upside, equities research analysts clearly believe McKesson is more favorable than Neogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, McKesson had 3 more articles in the media than Neogen. MarketBeat recorded 17 mentions for McKesson and 14 mentions for Neogen. McKesson's average media sentiment score of 0.57 beat Neogen's score of 0.08 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	6 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Neogen	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Neogen has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 0.5% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Neogen	-0.91%	2.78%	1.74%

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.78
Neogen	$870.40M	3.11	-$7.90M	-$0.03	N/A

Summary

McKesson beats Neogen on 11 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

McKesson (NYSE:MCK) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

In the previous week, McKesson had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 17 mentions for McKesson and 3 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat McKesson's score of 0.57 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	6 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson presently has a consensus target price of $973.44, suggesting a potential upside of 9.53%. AMN Healthcare Services has a consensus target price of $36.00, suggesting a potential downside of 1.91%. Given McKesson's stronger consensus rating and higher possible upside, research analysts plainly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.78
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.69

AMN Healthcare Services has a net margin of 3.06% compared to McKesson's net margin of 1.12%. AMN Healthcare Services' return on equity of 19.92% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
AMN Healthcare Services	3.06%	19.92%	5.93%

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

McKesson has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Summary

McKesson and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$105.30B	$9.69B	$7.10B	$22.70B
Dividend Yield	0.44%	2.60%	2.53%	3.74%
P/E Ratio	24.17	34.42	274.33	27.77
Price / Sales	0.26	4.84	601.06	20.15
Price / Cash	18.74	120.27	77.38	39.56
Price / Book	-62.24	5.15	10.92	4.64
Net Income	$4.76B	$315.68M	$3.50B	$1.08B
7 Day Performance	4.22%	-2.87%	-2.11%	-1.06%
1 Month Performance	-2.59%	-2.92%	-6.34%	-5.03%
1 Year Performance	18.89%	8.65%	8.81%	5.78%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.2336 of 5 stars	$903.14 +0.5%	$973.44 +7.8%	+17.7%	$105.30B	$403.43B	24.17	43,000	Trending News
HQY HealthEquity	4.2245 of 5 stars	$94.52 -0.7%	$112.20 +18.7%	-1.5%	$7.87B	$1.31B	34.12	2,814
HSIC Henry Schein	3.283 of 5 stars	$85.20 +0.4%	$92.93 +9.1%	+29.5%	$9.46B	$13.18B	24.84	25,000	Positive News
MMSI Merit Medical Systems	3.4995 of 5 stars	$85.49 +0.1%	$100.00 +17.0%	+5.0%	$5.10B	$1.52B	35.33	7,500	Analyst Forecast
NEOG Neogen	1.8853 of 5 stars	$13.61 +4.7%	$12.00 -11.8%	+111.0%	$2.84B	$870.40M	N/A	1,257	Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to Neogen?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Which has more risk and volatility, MCK or HQY?

Does the media refer more to MCK or HQY?

Do insiders & institutionals hold more shares of MCK or HQY?

Which has better earnings and valuation, MCK or HQY?

Is MCK or HQY more profitable?

Do analysts recommend MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Do institutionals & insiders believe in MCK or HSIC?

Which has higher valuation and earnings, MCK or HSIC?

Does the media favor MCK or HSIC?

Which has more volatility and risk, MCK or HSIC?

Is MCK or HSIC more profitable?

Do analysts rate MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Which has more volatility and risk, MCK or MMSI?

Do institutionals & insiders have more ownership in MCK or MMSI?

Which has stronger valuation and earnings, MCK or MMSI?

Do analysts rate MCK or MMSI?

Is MCK or MMSI more profitable?

Does the media favor MCK or MMSI?

Summary

How does McKesson compare to Neogen?

Do analysts rate MCK or NEOG?

Does the media favor MCK or NEOG?

Which has more risk & volatility, MCK or NEOG?

Do institutionals & insiders believe in MCK or NEOG?

Is MCK or NEOG more profitable?

Which has better valuation and earnings, MCK or NEOG?

Summary

How does McKesson compare to AMN Healthcare Services?

Does the media prefer MCK or AMN?

Do analysts prefer MCK or AMN?

Which has stronger valuation & earnings, MCK or AMN?

Is MCK or AMN more profitable?

Do insiders & institutionals hold more shares of MCK or AMN?

Which has more risk and volatility, MCK or AMN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools